TrialJournal of nephrology2015

Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial.

Mario Carmellini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.